January 9, 2026

Cartesian Therapeutics Reports Progress in Phase 3 AURORA Trial of Descartes-08 for Myasthenia Gravis and Initiates Pediatric Trial for Juvenile Dermatomyositis – Quiver Quantitative

January 9, 2026

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial – Nature

January 8, 2026

Women with MG have higher risk of complications during pregnancy – Myasthenia Gravis News

January 7, 2026

Early rituximab treatment may improve long-term outcomes in gMG – Myasthenia Gravis News

January 7, 2026

Stress-Related Urinary Incontinence Common With Myasthenia Gravis – American Journal of Managed Care